Peptides DB
Research-centric peptide and protocol reference hub

Pinealon (EDR) record · updated 8h ago

Neuro & moodSleep & circadianGrade D · emergingResearch use only
Jump to the evidenceCompare
What is Pinealon (EDR) used for?

Synthetic Tripeptide | Neuroprotection & Cognitive Enhancement

Primarily researched for · Neuro & mood

Development stage

where Pinealon (EDR) sits between preclinical work and regulatory approval
  1. 1Current
    Preclinical
    Animal / in-vitro work
  2. 2Not reached
    Phase 1
    Safety in humans
  3. 3Not reached
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus. It describes the research record, not a recommendation.

Identity
NamePinealon (EDR)
Full name
Sequence
ClassCognitive
Research levelWell Studied
Discovered byCurated master list · 2026
Pharmacology
Mechanism
Route
Half-life
Time to peak
Duration
Extraction confidence
Effect profile · 0–5
Neuro & mood: Healing 1.0, Muscle 0.0, Metabolic 0.0, Neuro 5.0, Sleep 4.0, Immune 1.0, Skin 0.0Healing & recovery — 1.0 / 5Neuro & mood — 5.0 / 5Sleep & circadian — 4.0 / 5Inflammation & immune — 1.0 / 5HealingMuscleMetabolicNeuroSleepImmuneSkin1.00.00.05.04.01.00.0
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o mini over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Jul 27, 2026. How this works →
Research stats
Total studies0
Human / animal / cellular0 / 0 / 0
Highest trial phasePreclinical
Years covered2015–2020
Latest study
Publication history
No publication years on file
Research funding
no NIH grants found
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work
Community reports
Positive Neutral Negative
Records

Study register

0 rowsOpen in the library →
StudyTypeYearSummary depth
No approved studies filed yet — the Librarian is still searching.